SufA - A bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation

Microbiology

Volumn 155, Issue 1, 2009, Pages 238-248

  Karlsson, Christofer ^a   Mörgelin, Matthias ^a   Coilin, Mattias ^a   Lood, Rolf ^a   Andersson, Marie Louise ^a   Schmidtchen, Artur ^a   Björck, Lars ^a   Frick, Inga Maria ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; FIBRINOGEN; PROTEIN SUFA; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; FIBRIN; SUBTILISIN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BLOOD CLOTTING; CONTROLLED STUDY; FIBRIN FORMATION; FINEGOLDIA MAGNA; GENE TARGETING; GRAM POSITIVE COCCI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; WILD TYPE; ANAEROBIC GROWTH; BACTERIUM TRANSFORMATION; CELL LINE; ENZYMOLOGY; GENETICS; KERATINOCYTE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); FINEGOLDIA MAGNA;

ANAEROBIOSIS; BACTERIAL PROTEINS; CELL LINE; FIBRIN; FIBRINOGEN; GENE TARGETING; GRAM-POSITIVE COCCI; HUMANS; KERATINOCYTES; SUBTILISIN; TRANSFORMATION, BACTERIAL;

EID: 61449101478     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.021311-0     Document Type: Article

References (43)

1. Bals, R. & Wilson, J. M. (2003). Cathelicidins - a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 60, 711-720.
2. Bowler, P. G. & Davies, B. J. (1999). The microbiology of infected and noninfected leg ulcers. Int J Dermatol 38, 573-578.
3. Camerer, E., Rottingen, J. A., Gjernes, E., Larsen, K., Skartlien, A. H., Iversen, J. G. & Prydz, H. (1999). Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 274, 32225-32233.
4. Collet, J. P., Moen, J. L., Veklich, Y. I., Gorkun, O. V., Lord, S. T., Montalescot, G. & Weisel, J. W. (2005). The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood 106, 3824-3830.
5. de Château, M. & Björck, L. (1994). Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J Biol Chem 269, 12147-12151.
6. de Château, M., Holst, E. & Björck, L. (1996). Protein PAB, an albumin-binding bacterial surface protein promoting growth and virulence. J Biol Chem 271, 26609-26615.
7. Drew, A. F., Liu, H., Davidson, J. M., Daugherty, C. C. & Degen, J. L. (2001). Wound-healing defects in mice lacking fibrinogen. Blood 97, 3691-3698.
8. Egesten, A., Eliasson, M., Johansson, H. M., Olin, A. I., Morgelin, M., Mueller, A., Pease, J. E., Frick, I. M. & Björck, L. (2007). The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195, 684-693.
9. Fischetti, V. A. (1989). Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2, 285-314.
10. Flores, A. E. & Ferrieri, P. (1996). Molecular diversity among the trypsin resistant surface proteins of group B streptococci. Zentralbl Bakteriol 285, 44-51.
11. Frick, I.-M., Karlsson, C., Mörgelin, M., Olin, A. I., Janjusevic, R., Hammarström, C., Holst, E., de Château, M. & Björck, L. (2008). Identification of a novel protein promoting the colonization and survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen. Mol Microbiol 70, 695-708.
12. Goto, T., Yamashita, A., Hirakawa, H., Matsutani, M., Todo, K., Ohshima, K., Toh, H., Miyamoto, K., Kuhara, S. & other authors (2008). Complete genome sequence of Finegoldia magna, an anaerobic opportunistic pathogen. DNA Res 15, 39-47.
13. Hansson, C., Hoborn, J., Moller, A. & Swanbeck, G. (1995). The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 75, 24-30.
14. Harris, T. O., Shelver, D. W., Bohnsack, J. F. & Rubens, C. E. (2003). A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 111, 61-70.
15. Hunzelmann, N., Hafner, M., Anders, S., Krieg, T. & Nischt, R. (1998). BM-40 (osteonectin, SPARC) is expressed both in the epidermal and in the dermal compartment of adult human skin. J Invest Dermatol 110, 122-126.
16. Karlsson, C., Andersson, M. L., Collin, M., Schmidtchen, A., Björck, L. & Frick, I. M. (2007). SufA - a novel subtilisin-like serine proteinase of Finegoldia magna. Microbiology 153, 4208-4218.
17. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
18. 0Laurens, N., Koolwijk, P. & de Maat, M. P. (2006). Fibrin structure and wound healing. J Thromb Haemost 4, 932-939.
19. Liotta, L. A. & Stetler-Stevenson, W. G. (1990). Metalloproteinases and cancer invasion. Semin Cancer Biol 1, 99-106.
20. Liu, C., Matsushita, Y., Shimizu, K., Makimura, K. & Hasumi, K. (2007). Activation of prothrombin by two subtilisin-like serine proteases from Acremonium sp. Biochem Biophys Res Commun 358, 356-362.
21. Mosesson, M. W. (2005). Fibrinogen and fibrin structure and functions. J Thromb Haemost 3, 1894-1904.
22. Murdoch, D. A. (1998). Gram-positive anaerobic cocci. Clin Microbiol Rev 11, 81-120.
23. Murdoch, D. A. & Shah, H. N. (1999). Reclassification of Peptostreptococcus magnus (Prevot 1933) Holdeman and Moore 1972 as Finegoldia magna comb. nov. and Peptostreptococcus micros (Prevot 1933) Smith 1957 as Micromonas micros comb. nov. Anaerobe 5, 555-559.
24. Oleksy, A., Golonka, E., Banbula, A., Szmyd, G., Moon, J., Kubica, M., Greenbaum, D., Bogyo, M., Foster, T. J. & other authors (2004). Growth phase-dependent production of a cell wall-associated elastinolytic cysteine proteinase by Staphylococcus epidermidis. Biol Chem 385, 525-535.
25. Persson, K., Russell, W., Morgelin, M. & Herwald, H. (2003). The conversion of fibrinogen to fibrin at the surface of curliated Escherichia coli bacteria leads to the generation of proinflammatory fibrinopeptides. J Biol Chem 278, 31884-31890.
26. Podbielski, A., Spellerberg, B., Woischnik, M., Pohl, B. & Lütticken, R. (1996). Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene 177, 137-147.
27. Rybarczyk, B. J., Lawrence, S. O. & Simpson-Haidaris, P. J. (2003). Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 102, 4035-4043.
28. Sahni, A. & Francis, C. W. (2000). Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96, 3772-3778.
29. Sahni, A., Guo, M., Sahni, S. K. & Francis, C. W. (2004). Interleukin-1β but not IL-1α binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 104, 409-414.
30. Schmidtchen, A., Frick, I. M. & Björck, L. (2001). Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol 39, 708-713.
31. Senior, R. M., Skogen, W. F., Griffin, G. L. & Wilner, G. D. (1986). Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 77, 1014-1019.
32. Simon, D. & Ferretti, J. J. (1991). Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol Lett 66, 219-224.
33. Singh, T. M., Kadowaki, M. H., Glagov, S. & Zarins, C. K. (1990). Role of fibrinopeptide B in early atherosclerotic lesion formation. Am J Surg 160, 156-159.
34. Skogen, W. F., Senior, R. M., Griffin, G. L. & Wilner, G. D. (1988). Fibrinogen-derived peptide B beta 1-42 is a multidomained neutrophil chemoattractant. Blood 71, 1475-1479.
35. Stephens, P., Wall, I. B., Wilson, M. J., Hill, K. E., Davies, C. E., Hill, C. M., Harding, K. G. & Thomas, D. W. (2003). Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br J Dermatol 148, 456-466.
36. Sun, H. (2006). The interaction between pathogens and the host coagulation system. Physiology 21, 281-288.
37. Sun, H., Ringdahl, U., Homeister, J. W., Fay, W. P., Engleberg, N. C., Yang, A. Y., Rozek, L. S., Wang, X., Sjöbring, U. & Ginsburg, D. (2004). Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305, 1283-1286.
38. Tang, Y. Q., Yeaman, M. R. & Selsted, M. E. (2002). Antimicrobial peptides from human platelets. Infect Immun 70, 6524-6533.
39. Travis, J. & Potempa, J. (2000). Bacterial proteinases as targets for the development of second-generation antibiotics. Biochim Biophys Acta 1477, 35-50.
40. Weisel, J. W. (2005). Fibrinogen and fibrin. Adv Protein Chem 70, 247-299.
41. Weisel, J. W. & Medved, L. (2001). The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci 936, 312-327.
42. Weisel, J. W. & Nagaswami, C. (1992). Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 63, 111-128.
43. Wolberg, A. S. (2007). Thrombin generation and fibrin clot structure. Blood Rev 21, 131-142.